Furthermore, cell-cycle-associated proteins including cyclin B1 and phosphorylated Cdc-2 also decreased due to MerTK inhibition by treatment with UNC2250, accompanied by G2/M phase arrest in MCL cells. The gene discussed is CCNB1; the disease is mantle cell lymphoma.